ENANTA PHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding from Q1 2013 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Enanta Pharmaceuticals Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2013 to Q3 2024.
  • Enanta Pharmaceuticals Inc Entity Common Stock, Shares Outstanding for the quarter ending November 5, 2024 was 21.2M shares, a 0.64% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 21.2M +135K +0.64% Nov 5, 2024 10-K 2024-11-27
Q2 2024 21.2M +133K +0.63% Aug 5, 2024 10-Q 2024-08-07
Q1 2024 21.2M +124K +0.59% Apr 30, 2024 10-Q 2024-05-08
Q4 2023 21.2M +270K +1.29% Jan 31, 2024 10-Q 2024-02-08
Q3 2023 21.1M +261K +1.26% Nov 1, 2023 10-K 2023-11-22
Q2 2023 21.1M +331K +1.6% Aug 1, 2023 10-Q 2023-08-08
Q1 2023 21.1M +343K +1.66% Apr 28, 2023 10-Q 2023-05-09
Q4 2022 20.9M +356K +1.74% Jan 31, 2023 10-Q 2023-02-08
Q3 2022 20.8M +473K +2.33% Nov 1, 2022 10-K 2022-11-23
Q2 2022 20.7M +510K +2.52% Aug 2, 2022 10-Q 2022-08-08
Q1 2022 20.7M +518K +2.56% Apr 27, 2022 10-Q 2022-05-09
Q4 2021 20.5M +358K +1.78% Jan 31, 2022 10-Q 2022-02-10
Q3 2021 20.3M +246K +1.22% Nov 1, 2021 10-K 2021-11-24
Q2 2021 20.2M +143K +0.71% Jul 29, 2021 10-Q 2021-08-09
Q1 2021 20.2M +191K +0.95% Apr 26, 2021 10-Q 2021-05-10
Q4 2020 20.2M +247K +1.24% Jan 31, 2021 10-Q 2021-02-09
Q3 2020 20.1M +353K +1.79% Nov 1, 2020 10-K 2020-11-25
Q2 2020 20.1M +391K +1.98% Jul 30, 2020 10-Q 2020-08-10
Q1 2020 20M +335K +1.7% Apr 30, 2020 10-Q 2020-05-11
Q4 2019 19.9M +483K +2.48% Jan 31, 2020 10-Q 2020-02-10
Q3 2019 19.7M +302K +1.55% Nov 1, 2019 10-K 2019-11-27
Q2 2019 19.7M +304K +1.57% Jul 30, 2019 10-Q 2019-08-09
Q1 2019 19.7M +402K +2.09% Apr 28, 2019 10-Q 2019-05-10
Q4 2018 19.4M +316K +1.65% Jan 31, 2019 10-Q 2019-02-08
Q3 2018 19.4M Nov 1, 2018 10-K 2018-11-29
Q2 2018 19.4M +287K +1.5% Aug 1, 2018 10-Q 2018-08-09
Q1 2018 19.3M +184K +0.97% May 1, 2018 10-Q 2018-05-10
Q4 2017 19.1M +87.1K +0.46% Dec 1, 2017 10-K 2017-12-11
Q2 2017 19.1M +54.5K +0.29% Aug 1, 2017 10-Q 2017-08-09
Q1 2017 19.1M +126K +0.67% May 1, 2017 10-Q 2017-05-10
Q4 2016 19M +114K +0.6% Dec 1, 2016 10-K 2016-12-09
Q2 2016 19M +322K +1.72% Aug 1, 2016 10-Q 2016-08-09
Q1 2016 19M +265K +1.42% May 1, 2016 10-Q 2016-05-10
Q4 2015 18.9M +245K +1.31% Jan 31, 2016 10-Q 2016-02-09
Q2 2015 18.7M +131K +0.71% Jul 31, 2015 10-Q 2015-08-10
Q1 2015 18.7M +154K +0.83% Apr 30, 2015 10-Q 2015-05-08
Q4 2014 18.7M +719K +4% Jan 30, 2015 10-Q 2015-02-06
Q2 2014 18.6M +671K +3.75% Aug 8, 2014 10-Q 2014-08-12
Q1 2014 18.5M +719K +4.04% May 9, 2014 10-Q 2014-05-12
Q4 2013 18M Dec 16, 2013 10-K 2013-12-18
Q2 2013 17.9M Aug 9, 2013 10-Q 2013-08-12
Q1 2013 17.8M May 10, 2013 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.